Managing Radiorecurrent Prostate Cancer with Dr. Jiten Jaipuria Podcast Por  arte de portada

Managing Radiorecurrent Prostate Cancer with Dr. Jiten Jaipuria

Managing Radiorecurrent Prostate Cancer with Dr. Jiten Jaipuria

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

👉 Visit https://oncoassist.com/ to streamline patient care with cutting-edge tools, guidelines, and calculators!

🎧 In this episode of Oncology Spotlight, we’re joined by Dr. Jiten Jaipuria, uro-oncologist and focal therapy specialist at Portsmouth Hospitals University NHS Trust, to explore a critical but often under-discussed topic: radiorecurrent prostate cancer.

With recurrence becoming more common in the era of precision oncology, Dr. Jaipuria explains:

  • How radiorecurrent prostate cancer is defined

  • The role of the Phoenix criteria and PSA thresholds

  • The growing importance of imaging (PSMA PET/MRI)

  • How to approach salvage therapies like cryotherapy, HIFU, brachytherapy, and more

  • Why a personalised treatment strategy is essential in recurrent cases

💬 “We have more tools than ever. It’s about picking the right one for the right patient.”

This is a must-listen for urologists, oncologists, radiotherapists, and care teams managing recurrent prostate cancer cases.

📢 JOIN THE CONVERSATION! ❓ What do you think is the biggest challenge in oncology nursing today? Drop your thoughts in the comments below!📲 Oncology at your fingertips.

Download the ONCOassist app:

📥 iOS: https://apple.co/4iuMxfS

📥 Android: https://bit.ly/oncoassistonandroid

📥Webapp: https://bit.ly/ONCOassistOnWeb

🌐 Learn more at: https://oncoassist.com/

🚀 SUBSCRIBE to the ONCOassist Youtube Channel for more expert insights!

🔔 Turn on notifications so you never miss an episode.

📌 FOLLOW US FOR UPDATES:

📍 LinkedIn: https://bit.ly/oncoassistlinkedin

📍 Twitter/X: https://bit.ly/oncoassisttwitter


#OncologySpotlight #ProstateCancer #RadiorecurrentProstateCancer #FocalTherapy #SalvageTherapy #RoboticSurgery #UroOncology #PSMAPET #OncoAlert

Todavía no hay opiniones